| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/12/2009 | CN101506236A Monoclonal antibodies against amyloid beta protein and uses thereof |
| 08/12/2009 | CN101506235A Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals |
| 08/12/2009 | CN101505795A Composition for modulating the expression of cell adhesion molecules |
| 08/12/2009 | CN101505794A scFV antibodies which pass epithelial and/or endothelial layers |
| 08/12/2009 | CN101505792A Tumor therapy with an anti-VEGF antibody |
| 08/12/2009 | CN101505786A A novel peptide involved in energy homeostasis |
| 08/12/2009 | CN101503701A Preparations of human rhinopharynx tissue specific gene C10RF102 coding protein, polyclonal antibody and monoclonal antibody thereof |
| 08/12/2009 | CN101503473A Targeted polypeptide for diagnosing and treating lung cancer in vivo and in vitro and use thereof |
| 08/12/2009 | CN101503472A Human source neutralizing antibody specific against botulinum neurotoxin type A and use thereof |
| 08/12/2009 | CN101503471A Monoclonal antibody of anti-rhabdovirus glucoprotein of mandarin fish, preparation and use thereof |
| 08/12/2009 | CN100526452C Colloidal gold immune chromatography fast differential diagnosis kit of chicken avian influenza vaccine immunity and virus strain infection and application |
| 08/12/2009 | CN100526331C CTL epitopes from EBV |
| 08/11/2009 | US7573601 Digital camera |
| 08/11/2009 | US7572904 Nucleotide sequences coding viral genome for use in developing vaccine to prevent respiratory system infections; genetic vaccines |
| 08/11/2009 | US7572900 Expression vector comprising breast cancer gene (BCL-2) nucleotide sequences for use as tool in treatment, diagnosis and prevention of cell proliferative disorders |
| 08/11/2009 | US7572899 Compositions and methods for increasing bone mineralization |
| 08/11/2009 | US7572897 Monoclonal antibody which binds insulin-like growth factor receptor (IGF-IR ) for use in diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents |
| 08/11/2009 | US7572896 Monoclonal antibodies that bind to antigen oncostatin M receptor beta subunit (OSM-R.beta); cancers |
| 08/11/2009 | US7572895 Transferrin receptor antibodies |
| 08/11/2009 | US7572772 Use preventing transplant rejection, treating autoimmune diseases, and in leukocyte typing and FAC sorting; CD28/CTLA4Ig fusion proteins |
| 08/11/2009 | US7572768 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 08/11/2009 | US7572766 IFBMs to promote the specific attachment of target analytes to the surface of orthopedic implants |
| 08/11/2009 | US7572763 Controlling cell differentiation; muscular disorders |
| 08/11/2009 | US7572621 Characterizing hepatitis C viral infection by determining a similarity between a viral sequence of an hypervariable region 1 (HVR1) of the second envelope protein (E2) region of an hepatitis C virus that infected the host and a variable region kappa light chain of an immunoglobulin of the host |
| 08/11/2009 | US7572591 Thrombotic thrombocytopenic purpura (TTP); epitope recognized by an antibody (anti-ADAMTS-13 antibody) against a cleaving protease ( ADAMTS-13) specific to von Willebrand factor |
| 08/11/2009 | US7572449 Vaccine against Yersinia comprising one or two antibodies, one specific for Yersinia pestis F1-antigen and the other one for Yersinia pestis V-antigen |
| 08/11/2009 | US7572448 antibody, immunoconjugate and duramycin-based compositions; bind and inhibit anionic phospholipids and aminophospholipids, for use in the safe and effective treatment of cancer, viral infections and related diseases |
| 08/11/2009 | US7572446 Antagonists of HMG1 for treating inflammatory conditions |
| 08/11/2009 | US7572443 Anti-Platelet endothelial cell adhesion molecule (PECAM); monoclonal antibodies; kits |
| 08/11/2009 | US7572442 Selected antibody compositions for binding to aminophospholipids |
| 08/11/2009 | US7572441 Media and method for treating pathological syndrome |
| 08/11/2009 | CA2348732C Human h37 proteins and cdnas encoding the same |
| 08/11/2009 | CA2328133C Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 08/11/2009 | CA2271248C Use of a notch ligand in immunotherapy |
| 08/11/2009 | CA2255113C Conductive metal-containing nucleic acids |
| 08/11/2009 | CA2241572C Apo-2 ligand |
| 08/11/2009 | CA2224404C Cell volume-regulated human kinase h-sgk |
| 08/06/2009 | WO2009097128A1 Membrane transporter napi2b (slc34a2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy |
| 08/06/2009 | WO2009097017A2 Antibodies and fc fusion protein modifications with enhanced persistence or pharmacokinetic stability in vivo and methods of use thereof |
| 08/06/2009 | WO2009096162A1 Composition for neutralizing botulinus toxin type-a, and human anti-botulinus toxin type-a antibody |
| 08/06/2009 | WO2009096112A1 Tag peptide and use thereof |
| 08/06/2009 | WO2009095665A1 Cell staining assay and kit |
| 08/06/2009 | WO2009095489A2 Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling |
| 08/06/2009 | WO2009095478A1 Antibodies against human cd39 and use thereof for inhibiting t regulatory cells activity |
| 08/06/2009 | WO2009095235A1 Methods to stabilize proteins and polypeptides |
| 08/06/2009 | WO2009094755A1 Monoclonal antibodies for ebola and marburg viruses |
| 08/06/2009 | WO2009094752A1 An anti-cancer cytotoxic monoclonal antibody |
| 08/06/2009 | WO2009094751A1 An anti-cancer cytotoxic monoclonal antibody |
| 08/06/2009 | WO2009068625A3 Amino acid sequences directed against her2 and polypeptides comprising the same for the treatment of cancers and/or tumors |
| 08/06/2009 | WO2009058957A3 Intranasal administration of active agents to the central nervous system |
| 08/06/2009 | WO2009055074A8 Erbb2 binding proteins and use thereof |
| 08/06/2009 | WO2009048769A3 Vaccinia virus h3l and b5r specific monoclonal antibodies and methods of making and using same |
| 08/06/2009 | WO2009047002A3 Products and their use for the diagnosis, prevention, and/or care of human and/or animal pathologies characterised by the anomalous deposition of b-amyloid and/or amyloid-like substance in human and/or animal organs and tissues, and screening method for determining the risk of such pathologies |
| 08/06/2009 | WO2008097582A8 Fluorescent single chain antibody (sc-fv) and its use in detection of analytes |
| 08/06/2009 | WO2008047242A8 Novel anti-cd38 antibodies for the treatment of cancer |
| 08/06/2009 | WO2008038127A8 Junctional adhesion molecule-c (jam-c) binding compounds and methods of their use |
| 08/06/2009 | US20090198044 Anti-psgl-1 antibodies |
| 08/06/2009 | US20090197801 Neuritogenic peptides |
| 08/06/2009 | US20090197776 Liquid Tissue Preparation From Histopathologically Processed Biological Samples, Tissues and Cells |
| 08/06/2009 | US20090197337 Methods for the production of multimeric proteins and related compositions |
| 08/06/2009 | US20090197330 Anti-cd20 monoclonal antibody |
| 08/06/2009 | US20090197317 TSG-Like Gene |
| 08/06/2009 | US20090197315 Fullerene-based amino acids |
| 08/06/2009 | US20090197303 Process for producing dipeptides |
| 08/06/2009 | US20090197301 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/06/2009 | US20090197278 Antibodies to hADA2 |
| 08/06/2009 | US20090197273 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 08/06/2009 | US20090197269 Translocation and mutant CSF1R Kinase in human leukemia |
| 08/06/2009 | US20090196883 synthetic P. vivax circumsporozoite protein useful as a diagnostic reagent, for antibody production, and as a vaccine protective against infection with any strain of P. vivax; malaria vaccine |
| 08/06/2009 | US20090196882 Methods of producing antibodies to zalpha11 cytokine receptors |
| 08/06/2009 | US20090196880 Cancer treatment using humanized antibodies that bind to EphB4 |
| 08/06/2009 | US20090196879 B-cell depleting agents, like anti-CD20 antibodies or fragments thereof for the treatment of chronic fatigue syndrome |
| 08/06/2009 | US20090196877 Novel Method to Increase Memory T Lymphocytes and Enhance Their Functions |
| 08/06/2009 | US20090196876 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 08/06/2009 | US20090196873 Methods and compositions for treating diseases targeting CDCP1 |
| 08/06/2009 | US20090196872 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 08/06/2009 | US20090196870 Binding constructs and methods for use thereof |
| 08/06/2009 | US20090196831 Nanostructures, methods of synthesizing thereof, and methods of use thereof |
| 08/06/2009 | CA2712605A1 Monoclonal antibodies for ebola and marburg viruses |
| 08/06/2009 | CA2712432A1 Methods to stabilize single variable domains |
| 08/06/2009 | CA2699916A1 Antibodies and fc fusion protein modifications with enhanced persistence or pharmacokinetic stability in vivo and methods of use thereof |
| 08/05/2009 | EP2085783A1 Use of NGF inhibitors in breast cancer therapy |
| 08/05/2009 | EP2085478A1 A long QT syndrome gene which encodes KVLQT1 and its association with minK |
| 08/05/2009 | EP2085467A2 Lutzomyia Longipalpis polypeptides and methods of use |
| 08/05/2009 | EP2085407A1 Treatment of idiopathic thrombocytopenic purpura |
| 08/05/2009 | EP2085096A2 Novel composition and methods for the treatment of immune related diseases |
| 08/05/2009 | EP2085095A1 Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart |
| 08/05/2009 | EP2084540A2 Methods of treating, diagnosing or detecting cancer |
| 08/05/2009 | EP2084539A2 Conformation specific antibodies that bind trefoil factors and methods of treating cancers and proliferation disorders using same |
| 08/05/2009 | EP2084298A1 Method for predicting therapeutic responsiveness to tnf-alpha blocking agents |
| 08/05/2009 | EP2084190A1 Lingo binding molecules and pharmaceutical use thereof |
| 08/05/2009 | EP2084189A2 Anti-cd20 antibodies and methods of use |
| 08/05/2009 | EP2084188A2 Antibodies to lymphotoxin-alpha |
| 08/05/2009 | EP2084187A2 Amino acid sequences that bind to a desired molecule in a conditional manner |
| 08/05/2009 | EP2084186A2 Antibody with protein a selectivity |
| 08/05/2009 | EP2084185A2 Human antibodies neutralizing human metapneumovirus |
| 08/05/2009 | EP2084181A1 A method and preparations for the diagnosis and therapy of multiple sclerosis and immune demyelinating polyneuropathy |
| 08/05/2009 | EP2083865A2 Methods for providing prophylactic surface treatment for fluid processing systems and components thereof |
| 08/05/2009 | EP2083864A2 Antagonists of pcsk9 |
| 08/05/2009 | EP2083863A1 Use of tgf-beta antagonists to treat infants at risk of developing bronchopulmonary dysplasia |